Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 6596 record(s)

Req # A-2024-000171

The review reports or any other records regarding the review of the license applications for the following Natural Health Products jamp-Sodium Phosphate Natural Product Number (NPN)80047562 Phosphate Novartis NPN80027202.

Organization: Health Canada

41 page(s)
November 2024

Req # A-2024-000236

Results related to a study contracted by Health Canada, under a tender titled "Study of the Market Size, Characteristics and Growth Trends of the Vaping Products Market in Canada and the Provinces.". Documents related to the final report…

Organization: Health Canada

106 page(s)
November 2024

Req # A-2024-000324

All external correspondence between employees of Health Canada at the Director level and above AND employees of Global Health Imports Corporation, also known as Global Health Imports (GHI), Global Healthcare Solutions (GHS), including but not…

Organization: Health Canada

0 page(s)
November 2024

Req # A-2024-000327

All communications, to the named establishment and from Health Canada regarding the inspection and inspection outcomes related to the following establishment license holder and specified inspection dates: Establishment name: Winnipeg Regional…

Organization: Health Canada

90 page(s)
November 2024

Req # A-2024-000516

Provide a screenshot of the status page for the AVAPRITINIB New Drug Submission (NDS) on the Drug Submission Tracking System (DSTS) interface.

Organization: Health Canada

1 page(s)
November 2024

Req # A-2024-000528

Provide a screenshot of the status page for the Nov 2023 Liraglutide Abbreviated New Drug Submission (ANDS) on the Drug Submission Tracking System (DSTS) interface.

Organization: Health Canada

2 page(s)
November 2024

Req # A-2024-000531

If the December 2021 Liraglutide Abbreviated New Drug Submission (ANDS) received a Notice of Deficiency (NOD); a Notice of Non-Compliance (NON); a NOD-Withdrawal (NOD-W); or a NON-Withdrawal (NON-W). Provide the month and year that the notice was…

Organization: Health Canada

27 page(s)
November 2024

Req # A-2024-000537

The most recent Module 2.3: Quality Overall Summary (QOS) submitted the sponsor for the April 2024 Liraglutide Abbreviated New Drug Submission (ANDS).

Organization: Health Canada

72 page(s)
November 2024

Req # A-2024-000539

A screenshot of the status page for the Feb 2024 Semaglutide Abbreviated New Drug Submission (ANDS) on the Drug Submission Tracking System (DSTS) interface.

Organization: Health Canada

1 page(s)
November 2024

Req # A-2024-000546

Documents showing the most current status of the Abbreviated New Drug Submission (ANDS) seeking approval of a generic liraglutide product, which was accepted into review by Health Canada in November 2023: Inactive; Process; Process Hold; Withdrawn.

Organization: Health Canada

2 page(s)
November 2024
Date modified: